• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125275-08
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 07/26/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).The device was returned for analysis.The reported balloon leak was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot.Per xience alpine everolimus eluting coronary stent system instructions for use (ifu) instructs the user to remove the device from the protective tubing and flush the guide wire lumen.Prepare the device by removing air from the system, then it can be used in the anatomy.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Event or Problem Description
It was reported that during device preparation, air aspiration was performed in the anatomy.The procedure was to treat a mildly calcified and eccentric de novo proximal left anterior descending artery that was 85% stenosed.Pre-dilatation was performed and a 2.75 x 08 mm xience alpine stent delivery system was advanced to the lesion.An attempt was made to pressurize the balloon when contrast could be seen leaking from the balloon when it was inflated to 4 atmospheres.The stent implant had not deployed yet, so the device was removed without issue.Another 2.75 x 08 mm xience alpine stent was successfully deployed to complete the procedure.There was no clinically significant delay in procedure and no adverse patient effects.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6809303
Report Number2024168-2017-06843
Device Sequence Number16660518
Product Code NIQ
UDI-Device Identifier08717648199233
UDI-Public08717648199233
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 08/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/18/2019
Device Catalogue Number1125275-08
Device Lot Number6051141
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2017
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/27/2017
Initial Report FDA Received Date08/21/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-